Inhibition of human ether-a-go-go-related gene K+ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 2, 2005, Pages 888-895

  Choi, Se Young ^a   Koh, Young Sang ^b   Jo, Su Hyun ^b  

^a School of Dentistry   (South Korea)

^b Jeju National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL; NEUROLEPTIC AGENT; POTASSIUM CHANNEL HERG; TRIFLUOPERAZINE;

ANIMAL CELL; ARTICLE; DRUG EFFECT; DRUG INHIBITION; GUINEA PIG; HEART MUSCLE CELL; IC 50; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RECEPTOR BLOCKING; TORSADE DES POINTES; XENOPUS;

ANIMALS; ANTIPSYCHOTIC AGENTS; CATION TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; GUINEA PIGS; HUMANS; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; TRIFLUOPERAZINE; XENOPUS LAEVIS;

EID: 18044374124     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.080853     Document Type: Article

References (34)

1. Arita M and Surawicz B (1973) Electrophysiologic effects of phenothiazines on canine cardiac fibers. J Pharmacol Exp Ther 184:619-630.
2. Buckley NA and Sanders P (2000) Cardiovascular adverse effects of antipsychotic drugs. Drug Saf 23:215-228.
3. Carmeliet E (1992) Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 262:809-817.
4. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, and Keating MT (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80:795-803.
5. Ereshefsky L (1996) Pharmacokinetics and drug interactions: update for new antipsychotics. J Clin Psychiatry 57 (Suppl 11):12-25.
6. Faber TS, Zehender M, and Just H (1994) Drug-induced torsade de pointes. Incidence, management and prevention. Drug Saf 11:463-476.
7. Heath BM and Terrar DA (1996) Separation of the components of the delayed rectifier potassium current using selective blockers of IKr and IKs in guinea-pig isolated ventricular myocytes. Exp Physiol 81:587-603.
8. Herzer T, Busch AE, Waldegger S, and Lang F (1994) Inhibition of human IsK channels expressed in Xenopus oocytes by calmodulin antagonists. Eur J Pharmacol 259:335-338.
9. Hondeghem LM and Snyders DJ (1990) Class III antiarrhythmic agents have a lot of potential but a long way to go: reduced effectiveness and dangers of reverse use-dependence. Circulation 81:686-690.
10. Hull BE and Lockwood TD (1986) Toxic cardiomyopathy: the effect of antipsychotic-antidepressant drugs and calcium on myocardial protein degradation and structural integrity. Toxicol Appl Pharmacol 86:308-324.
11. Jo SH, Cho CH, Chae SW, and Lee CO (2000) Role of protein kinase C in alpha(1)-adrenergic regulation of a(Na)(i) in guinea pig ventricular myocytes. Am J Physiol 279:H1661-H1668.
12. Jusic N and Lader M (1994) Post-mortem antipsychotic drug concentrations and unexplained deaths. Br J Psychiatry 165:787-791.
13. Kelly HG, Fay JE, and Laverty SG (1963) Thioridazine hydrochloride (mellaril): its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities. Can Med Assoc J 89:546-554.
14. Kiehn J, Lacerda AE, Wible B, and Brown AM (1996) Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide. Circulation 94:2572-2579.
15. Lathers CM and Lipka LJ (1987) Cardiac arrhythmia, sudden death and psychoactive agents. J Clin Pharmacol 27:1-14.
16. Lipka LJ, Lathers CM, and Roberts J (1988) Does chlorpromazine produce cardiac arrhythmia via the central nervous system? J Clin Pharmacol 28:968-983.
17. Minetti M and Di Stasi AM (1987) Involvement of erythrocyte skeletal proteins in the modulation of membrane fluidity by phenothiazines. Biochemistry 26:8133-8137.
18. Raehl CL, Patel AK, and LeRoy M (1985) Drug-induced torsade de pointes. Clin Pharm 4:675-690.
19. Rampe D, Roy ML, Dennis A, and Brown AM (1997) A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG. FEBS Lett 417:28-32.
20. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, and Thomas SH (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355:1048-1052.
21. Sanguinetti MC, Jiang C, Curran ME, and Keating MT (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81:299-307.
22. + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96:195-215.
23. Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32:229-313.
24. Snyders J, Knoth KM, Roberds SL, and Tamkun MM (1992) Time-, voltage- and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol Pharmacol 41:322-330.
25. Stavitsky AB, Dasch JR, and Astrachan L (1984) Effects of trifluoperazine, a calmodulin antagonist, on rabbit T- and B-cell responses to mitogens and antigen. Cell Immunol 87:411-423.
26. Suessbrich H, Schonherr R, Heinemann SH, Attali B, Lang F, and Busch AE (1997) The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br J Pharmacol 120:968-974.
27. Suessbrich H, Waldegger S, Lang F, and Busch AE (1996) Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett 385:77-80.
28. Taglialatela M, Castaldo P, Pannaccione A, Giorgio G, and Annunziato L (1998) Human ether-a-gogo related gene (HERG) K+ channels as pharmacological targets: present and future implications. Biochem Pharmacol 55:1741-1746.
29. Thomas D, Wendt-Nordahl G, Rockl K, Ficker E, Brown AM, and Kiehn J (2001) High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872. J Pharmacol Exp Ther 297:753-761.
30. Varnum MD, Busch AE, Bond CT, Maylie J, and Adelman JP (1993) The min K channel underlies the cardiac potassium current IKs and mediates species-specific responses to protein kinase C. Proc Natl Acad Sci USA 90:11528-11532.
31. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, et al. (1996) Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12:17-23.
32. Weiss B, Prozialeck WC, and Wallace TL (1982) Interaction of drugs with calmodulin. Biochemical, pharmacological and clinical implications. Biochem Pharmacol 31:2217-2226.
33. Witchel HJ, Hancox JC, and Nutt DJ (2003) Psychotropic drugs, cardiac arrhythmia and sudden death. J Clin Psychopharmacol 23:58-77.
34. Zhou Z, Gong Q, Ye B, Fan Z, Makielski JC, Robertson GA, and January CT (1998) Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 74:230-241.